For families pursuing IVF or surrogacy, transferring a genetically tested embryo can feel like a major milestone. But the journey doesn’t end there. A common and often stressful question soon arises: 🧪 If our embryo passed Preimplantation Genetic Testing for Aneuploidy (PGT-A), do we still need amniocentesis?
This decision can be emotionally challenging—balancing a desire for certainty with the risks of an invasive test. To decide confidently, it’s important to understand the difference between screening (PGT-A) and diagnostic testing (like amniocentesis).
🔬 What Are Diagnostic Prenatal Tests?
Diagnostic tests provide clear, definitive answers about the fetus’s genetic health.
Amniocentesis (Amnio)
This is a second-trimester diagnostic procedure that analyzes a sample of amniotic fluid, which contains fetal cells. It’s typically performed between 15 and 20 weeks of pregnancy. If you’re unsure about your current gestational week, our Due Date Calculator can help you estimate the right timing for this test. It can detect:
- Chromosomal abnormalities (e.g., Down syndrome, Edwards syndrome)
- Single-gene disorders (e.g., cystic fibrosis, sickle cell anemia)
- Neural tube defects (e.g., spina bifida)
- In certain cases: fetal lung maturity and Rh incompatibility
🧫 Chorionic Villus Sampling (CVS)
CVS is an earlier diagnostic test (10–13 weeks), using placental tissue (chorionic villi). It can detect the same genetic disorders as amnio—except neural tube defects.
⚠️ Risks and Safety
Both amniocentesis and CVS are considered safe in experienced hands, but they do carry risks:
- Miscarriage (ACOG estimates: 0.1%–0.3%)
- Amniotic fluid leakage
- Infection
- Fetal injury (very rare)
Because of these risks, these tests are typically reserved for situations where the benefit of diagnosis outweighs the risk.
🧬 How Does PGT-A Compare to Diagnostic Testing?
PGT-A is an advanced screening tool—not a diagnostic test.
✅ PGT-A (Preimplantation Genetic Testing for Aneuploidy):
- Tests 5–10 cells from the embryo’s trophectoderm (future placenta)
- Screens for chromosomal number and structure
- Helps select embryos with the best potential for implantation and healthy development
- Accuracy: ~95–98%, but not 100%
🧪 Amniocentesis / CVS:
- Tests hundreds of actual fetal cells
- Offers a definitive diagnosis
- Can detect abnormalities missed by PGT-A
❓ Why Isn’t PGT-A 100% Accurate?
The key issue: Mosaicism.
- PGT-A samples the outer layer (trophectoderm), not the inner cell mass that becomes the baby.
- In rare cases, the placenta and fetus may have different genetics—this is called confined placental mosaicism.
- So, an embryo that tested “normal” during PGT-A may still result in a fetus with a chromosomal condition.
🧬 Real Case Example (from clinical experience):
In one IVF-surrogacy case, a PGT-A euploid embryo was transferred, but the fetus was later diagnosed with Trisomy 18 (Edwards syndrome) through amniocentesis. 👉 This illustrates why PGT-A cannot replace diagnostic testing when certainty is needed.
🔍 Do You Still Need Amniocentesis After PGT-A?
You might need or choose amniocentesis in these situations:
1. Abnormal Results from Other Screenings
If your NIPT, NT scan, or anatomy ultrasound suggests abnormalities, amnio is the gold standard for confirmation—even if PGT-A was done. Important: NIPT analyzes placental DNA too, and may reflect mosaicism just like PGT-A.
👉 Related Case Study: A real-life story illustrates this exact scenario. A surrogate carrying a PGT-A-tested embryo received a false-positive NIPT result for Trisomy 13. Amniocentesis later confirmed the fetus was chromosomally normal. 📖 Read the full story →
2. Family History of Genetic Conditions
PGT-A screens for chromosomal abnormalities only. If there’s a known risk for single-gene disorders, amnio can test for those directly.
3. Peace of Mind
Some intended parents choose amnio simply to feel fully reassured, especially after previous losses or anxiety-filled pregnancies.
✅ When Might Amniocentesis Not Be Necessary?
You may safely skip amnio when:
- The embryo was PGT-A euploid
- All follow-up screenings (NIPT, NT, ultrasounds) are normal
- There’s no family history or high-risk indication
In these cases, the residual risk is extremely low, and many opt to avoid the (albeit small) procedural risk.
🤝 Conclusion: A Personal Decision
Amniocentesis is the most accurate tool we have to confirm fetal genetic health. While PGT-A greatly reduces the likelihood of chromosomal issues, it does not eliminate them.
📌 Key Takeaways:
- Screening ≠ Diagnosis: PGT-A and NIPT assess risk; amnio provides answers
- Mosaicism matters: PGT-A may not reflect the fetus’s true genetics
- Red flags require follow-up: Abnormal scans or test results = diagnostic testing
- It’s your choice: Base your decision on screening results, personal comfort, and medical advice
🩺 Always consult with your OB/GYN, genetic counselor, and IVF team to make the best decision for your family’s journey.
📋 Frequently Asked Questions (FAQ)
1. Is PGT-A considered a diagnostic test like amniocentesis?
No. PGT-A is a screening test, not a diagnostic test. It estimates the risk of chromosomal abnormalities but cannot confirm them. Diagnostic tests like amniocentesis analyze fetal cells directly and offer definitive results.
2. If my embryo is PGT-A normal, can the fetus still have a genetic condition?
Yes. While PGT-A greatly reduces the risk, it doesn’t eliminate it entirely due to the possibility of mosaicism or other undetectable conditions.
3. What is mosaicism, and how does it affect PGT-A accuracy?
Mosaicism means the embryo contains both normal and abnormal cells. Since PGT-A samples only a few cells from the outer layer (trophectoderm), it may not fully represent the genetic makeup of the actual fetus.
4. Can I rely only on NIPT if I’ve already done PGT-A?
Not entirely. Both PGT-A and NIPT analyze placental DNA, which means they share similar limitations. If NIPT results are abnormal, diagnostic testing like amniocentesis is recommended.
5. When is amniocentesis typically performed during pregnancy?
Amniocentesis is usually performed between 15 and 20 weeks of gestation. It provides time-sensitive, detailed information about the fetus’s genetic health.
6. Is amniocentesis safe for the surrogate or pregnant person?
Yes, when performed by an experienced provider, amniocentesis is generally safe. The miscarriage risk is low (0.1%–0.3%), but the decision should be based on individual risk and need.
7. Should I consider amniocentesis if I have no abnormal findings and no family history?
In most cases, no. If the embryo was PGT-A tested and all follow-up prenatal screenings (NIPT, ultrasound) are normal, amniocentesis is typically not recommended due to the small procedural risk.
8. Who should I talk to before deciding about amniocentesis?
Always consult with your OB/GYN, genetic counselor, and fertility doctor. They can help assess your specific case and guide you based on your medical history, test results, and personal concerns.
Medically reviewed by Dr. Diana LeBlanc, MD – Reproductive Endocrinologist at Hanabusa IVF
